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ABSTRACT
Objective: The aim of the current study is to evaluate the effect of pterostilbene (PTS), on deranged plasma and tissue glycoprotein components in 
high-fat-diet (HFD) and streptozotocin (STZ)-induced type 2 diabetic mice.
Methods: The experimental duration was 16 weeks. The C57BL6/J mice were fed a normal diet, normal diet with PTS, HFD, and STZ injection 
(10th week only), and diabetic mice with PTS for the past 6 weeks.
Results: A significant increase in glycoprotein components such as hexose, hexosamine, fucose, and sialic acid (SA) in plasma was observed in diabetic 
mice. In hepatic and renal tissues, a significant decrease in SA with an increase in other glycoprotein components was detected in diabetic mice when 
compared with control mice. Oral administration of PTS significantly improved the glycoprotein levels in plasma and tissues of diabetic mice to near 
normal level.
Conclusion: In this study, we resolved that PTS improves disturbed glycoprotein metabolism in HFD and STZ-induced type 2 diabetic mice.
Keywords: Pterostilbene, High-fat diet, Streptozotocin, Hexosamine, Fucose, Sialic acid.
INTRODUCTION
Diabetes mellitus is a multifaceted disease characterized by unusual 
metabolism of carbohydrates, lipids, and proteins, and type 2 diabetes 
mellitus (T2DM) is the most dominant form of diabetes, which presents 
in more than 90% of diabetic cases [1]. Diabetes has develop one of the 
most challenging health problems on a global scale. The International 
Diabetes Federation (IDF) estimated that, in 2017, there were 451 
million (age 18–9 years) people with diabetes worldwide and this 
number was predicted to rise to 693 million by 2045 [2]. Diabetes 
is now showing an alarming increase in prevalence in developing 
countries. India alone, the prevalence of diabetes is expected to 79.4 
million in 2030, i.e. one-sixth of the world total [3].
Hyperglycemia and insulin deficiency, the hallmarks of diabetes 
mellitus, alter glycoprotein components in various tissues. Several 
studies reported that impaired metabolism of glycoproteins plays a 
major role in the pathogenesis of diabetic complications [4]. Under 
diabetic conditions, reactive oxygen species is produced mainly 
through glycation reaction, which occurs in various tissues and may 
play an important role in the development of diabetic complications [5]. 
Advanced glycation end-products modify galactose, fucose, and sialic 
acid (SA) contents of specific cellular glycoproteins [6]. This process 
leads to long-term damage, dysfunction, and failure of various organs, 
especially the eyes, kidney, nerves, heart, and blood vessels, and 
creates a huge economic burden related to the management of diabetic 
complications [7].
Glycoproteins are conjugated proteins that have one or more covalently 
connected carbohydrate chains which donate to the structure of 
extracellular matrix in animal cells. The principle forms of sugar 
present are hexose, hexosamine, fucose, and SA, which encrypt the 
diverse biological roles of glycoproteins [8]. Glycoproteins are main 
components of intracellular matrix, cell membrane, and membranes of 
the subcellular organelles. They play a vital role in the maintenance of 
structural integrity of the membrane bilayer. Cell surface glycoproteins 
have important roles in the transport of vitamins and lipids, in signal 
transduction as hormone receptors and in immunological specificity [9].
Pterostilbene (PTS) is a naturally derived compound found primarily 
in blueberries and Pterocarpus marsupium heartwood [10]. Substantial 
evidence suggests that PTS may have numerous preventive and 
therapeutic properties in a vast range of human diseases that include 
neurological, cardiovascular, metabolic, and hematologic disorders. 
Further benefits of PTS have been reported in preclinical trials, in 
which PTS was shown to be a potent anticancer agent in several 
malignancies [11]. PTS is structurally similar to resveratrol, a compound 
found in red wine that has comparable antioxidant, anti-inflammatory, 
and anticarcinogenic properties; however, PTS exhibits increased 
bioavailability due to the presence of two methoxy groups which cause it 
to exhibit increased lipophilic and oral absorption. In animal studies, PTS 
was shown to have 80% bioavailability compared to 20% for resveratrol 
making it potentially advantageous as a therapeutic agent [12].
The present study is aimed to investigate the ameliorative potential 
of PTS on glucose, insulin, and glycoprotein components (hexose, 
hexosamine, fucose, and SA) in plasma and tissues (the liver and 
kidney) of high-fat diet (HFD)/STZ-induced diabetic mice.
METHODS
Experimental animals and animal ethical
Healthy adult male C57BL/6J mice 3 weeks of age were obtained from 
BioGen Laboratory Animal Facility, Bengaluru, India, and housed in 
polypropylene cages. The animals were housed in well-ventilated 
polypropylene cages and controlled environment (temperature 
23±2°C, humidity 65–70%, and 12 h light/dark cycle) in the Central 
Animal House, Department of Experimental Medicine, Rajah Muthiah 
Medical College, Annamalai University. Animals were maintained under 
standard conditions with a 12 h light/dark cycle and were provided with 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i5.32940
Research Article
192
Asian J Pharm Clin Res, Vol 12, Issue 5, 2019, 191-194
 Thangasamy and Pari 
standard pellet diet and water ad libitum. All studies were conducted in 
accordance with the National Institute of Health, “guide for the care and 
use of laboratory animals” and CPCSEA guidelines. The study protocols 
were approved by the Institutional Animal Ethics Committee of Rajah 
Muthiah Medical College and Hospital (Reg. No. 160/1999/CPCSEA, 
Proposal number: 972), Annamalainagar.
Experimental induction of diabetes
Diabetes was induced in male C57BL/6J mice by feeding a HFD containing 
35% fat (beef tallow mixed with the diet) for 60 days; in addition, 
streptozotocin (STZ) was injected at a low dose in the 10th week.
Experimental design
Test animals were fed initially, before the study, with standard diets for 
2 weeks. Then, these mice were assigned to one of the four groups with 
six mice in each group:
Group 1 Mice received standard pellet diet for 16 weeks
Group 2 Mice received PTS (40 mg/kg BW) for 16 weeks
Group 3 Mice received HFD for 16 weeks and STZ was injected at 
10th week
Group 4 Diabetic mice received PTS (40 mg/kg BW) for the last 
6 weeks
PTS: Pterostilbene, HFD: High-fat diet, STZ: Streptozotocin
Extraction of glycoproteins
To 0.1 ml of plasma, 5.0 ml of methanol was added, mixed well, and 
centrifuged for 10 min at 3000× g. The supernatant was decanted 
and the precipitate was again washed with 5.0 ml of 95% ethanol 
and recentrifuged, and the supernatant was decanted to obtain the 
precipitate of glycoproteins. This was used for the estimation of hexose 
and hexosamine.
For extraction of glycoproteins from the tissues, a known weight of the 
tissue was homogenized in 7.0 ml of methanol. The contents were filtered 
and homogenized with 14.0 ml of chloroform. This was filtered and the 
residue was successively homogenized in chloroform-methanol (2:1v/v), 
and each time, the extract was filtered. The residue (defatted tissues) was 
obtained and the filtrate was decanted. A weighed amount of defatted 
tissue was suspended in 3.0 ml of 2 N HCl and heated at 90°C for 4 h. The 
sample was cooled and neutralized with 3.0 ml of 2 N NaOH. Aliquots 
from this were used for the estimation of hexose, hexosamine, and SA.
Determination of glycoproteins levels
Hexose was estimated by the method of Niebes [13]. The reaction 
mixture contained 0.5 ml of tissue homogenate/plasma, 0.5 ml of 5% 
phenol, and 2.5 ml of concentrated H2SO4 and boiled for 20 min, and 
absorbance was read at 490 nm. Hexosamine was estimated by the 
method of Elson and Morgan [14], with slight modifications by Niebes. 
Briefly, the reaction mixture contained 0.5 ml plasma/1.0 ml tissue 
homogenate and 2.5 ml of 3N HCl. It was boiled for 6 h and neutralized 
with 6N NaOH. To 0.8 ml of the neutralized sample, add 0.6 ml of 
acetylacetone reagent and boiled for 30 min. The mixture was treated 
with 2.0 ml of Ehrlich’s reagent. The color developed was read at 540 
nm colorimetrically.
SA was determined by the method of Warren [15]. In brief, 0.5 ml of 
tissue homogenate/plasma was treated with 0.5 ml of deionized water 
and 0.25 ml of periodic acid and incubated at 37°C for 30 min. 0.2 ml 
of sodium meta-arsenate and 2.0 ml of thiobarbituric acid were added 
to the reaction mixture which was heated for 6 min. 5.0 ml of acidified 
butanol was then added and the absorbance was read at 540 nm.
Fucose was estimated by the method of Dische and Shettles [16]. 
Briefly, 0.5 ml of tissue homogenate/plasma was treated with 4.5 ml 
of H2SO4 and boiled for 3 min. 0.1 ml of cysteine hydrochloride reagent 
was then added. After 75 min in the dark, the absorbance was read at 
393 and 430 nm. The glycoprotein levels were expressed as mg/100 g 
for defatted tissue and mg/dl for plasma.
Histopathological examination of the kidney
For histopathological studies, the kidney was excised from each group. 
Each tissue was fixed in 10% formalin and embedded in paraffin. 
The prepared paraffin blocks were later sectioned (5 μm) using a 
microtome, deparaffinated in xylene, passed through alcohol, stained 
with hematoxylin-eosin, and examined under a light microscope 
(Nikon, Tokyo, Japan).
Statistical analysis
The results were expressed as a mean standard deviation for six 
mice (n=6) in each group. Data were analyzed by one-way analysis of 
variance followed by Duncan’s multiple range test using SPSS version 
17 (SPSS, Chicago, IL). Post hoc testing was performed for intergroup 
comparisons using the least significant difference test. p<0.05 was 
considered as statistically significant.
RESULTS
Table 1 shows the changes in the levels of hexose, hexosamine, fucose, 
and SA in plasma of control and experimental mice. There was a 
significant increase in plasma glycoproteins in HFD/STZ-induced 
diabetic mice when compared to normal control mice. Administration of 
PTS to diabetic mice resulted in a significant reduction of glycoproteins 
in the plasma when compared to diabetic control mice.
The levels of glycoproteins in liver and kidney tissues of control and 
experimental mice are shown in Tables 2 and 3. The levels of SA were 
significantly decreased in the tissues of HFD-induced diabetic mice, 
Table 1: Effect of PTS on plasma glycoproteins in normal and experimental mice
Groups Hexose (mg/dl) Hexosamine (mg/dl) Fucose (mg/dl) Sialic acid (mg/dl)
Normal control 90.23±6.87a 69.72±5.30a 29.33±2.23a 56.36±4.29a
Normal+PTS (40 mg/kg b.w) 89.47±6.84a 66.32±5.07a 29.16±2.23a 54.45±4.16a
HFD+STZ 141.35±10.76b 92.42±7.03b 48.43±3.68b 75.43±5.74b
HFD+HFD+PTS (40 mg/kg b.w) 103.22±7.90c 73.56±5.63c 33.85±2.59c 62.39±4.77c
Values are means±SD for six mice. Values not sharing a common superscript (a, b, and c) differ significantly at p<0.05 (DMRT). PTS: Pterostilbene, HFD: High-fat diet, 
STZ: Streptozotocin, SD: Standard deviation, DMRT: Duncan’s multiple range test
Table 2: Changes in the levels of liver glycoproteins in normal and experimental mice
Groups Hexose (mg/g) Hexosamine (mg/g) Fucose (mg/g) Sialic acid (mg/g)
Normal control 41.64±3.17a 17.37±1.32a 15.82±1.20a 10.42±0.79a
Normal+PTS (40 mg/kg b.w) 38.60±2.95a 18.83±1.43a 16.94±1.29a 10.02±0.76a
HFD+STZ 58.13±4.42b 43.42±3.30b 34.87±2.65b 04,27±0.32b
HFD+HFD+PTS (40 mg/kg b.w) 45.80±3.50c 22.34±1.71c 19.44±1.48c 07,33±4.77c
Values are means±SD for six mice. Values not sharing a common superscript (a, b, and c) differ significantly at p<0.05 (DMRT). PTS: Pterostilbene, HFD: High-fat diet, 
STZ: Streptozotocin, SD: Standard deviation, DMRT: Duncan’s multiple range test
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whereas an increase in protein-bound hexose, hexosamine, and fucose 
was observed. Oral administration of PTS to HFD-induced diabetic mice 
significantly reversed these changes in tissues to near normal.
Fig. 1 shows the histopathological changes in the kidney of different 
groups of mice. In HFD/STZ-fed diabetic mice, segmented glomerulo-
nephritis and fat accumulation in the tubules were observed (1c). Ad-
ministration of PTS showed cloudy swelling and mild fat accumulation 
in tubules.
DICUSSION
Diabetes is a progressive disease whose biochemical basis for 
progression and complications is poorly understood [17]. In the 
diabetic state, glucose is redirected through insulin-independent 
pathways resulting in enhanced production of carbohydrate moieties of 
glycoproteins. Therefore, there is an elevation in the levels of protein-
bound hexose, hexosamine, fucose, and SA in plasma of diabetic animals. 
Sustained hyperglycemia increases the expression of glutamine: 
Fructose-6-phosphate aminotransferase, the rate-limiting enzyme of 
the hexosamine pathway leading to an increase in the levels of hexose 
and hexosamine in plasma and tissues [18].
Protein-bound hexose contributes hydrophilic nature to the cell 
membrane and hexosamine through its cationic charges makes cell 
membrane polarized [19]. In our study, diabetic mice showed increased 
levels of hexose and hexosamine in plasma, hepatic, and renal tissues. 
Administration of PTS to diabetic mice significantly reduced their levels 
to near normal. Our results are in concordance with Saravanan and 
Pari, who reported that administration of thymol improved hexose and 
hexosamine levels in diabetic mice [20].
Fucose is a member of a group of eight essential sugars that the body 
requires for the optimal functioning of cell-to-cell communication 
and its metabolism appears to be altered in various diseases such as 
diabetes mellitus [21]. Fucose and sialic acid form specific structures 
called glycanic chains covalently linked to lipids or proteins which are 
present on the cell surface. The fucose level could be increased due to 
increased glycosylation in diabetic condition [22]. In the present study, 
a rise in fucose levels could be due to increased glycosylation in diabetic 
condition. Oral administration of PTS has restored the level of fucose to 
near normal which could be due to improved glycemic control.
SA is widely distributed in tissues and circulation. It is an acetylated 
derivative of neuraminic acid and is an essential component of 
glycoproteins and glycolipids. It is covalently bound to glycoproteins as the 
terminal sugar of oligosaccharide chains. Elevated levels of serum SA are 
considered to be a good predictor of cardiovascular disease [23]. Diabetic 
mice had increased levels of SA in the plasma and a decrease in tissues 
[24]. The increased levels of SA reported in diabetic mice might be due 
to either enhanced SA synthesis or decreased sialidase activity. However, 
decreased level of SA is observed in the tissues of diabetic mice which may 
be related to increased synthesis of fibronectin, which contains SA in its 
core structure. Further, the decreased tissue SA levels are associated with 
oxidative stress-induced desialylation of glycoproteins [25]. Treatment 
with PTS has normalized SA levels in the plasma and tissues of diabetic 
mice, which could be due to the regulation of sialidase activity by insulin, 
since insulin is a more likely mediator of SA changes.
Histopathological examination of the kidney of diabetic mice revealed 
morphological changes. The kidney of HFD/STZ-induced mice showed 
segmented glomerulonephritis and tubule shows fat accumulation. 
Treatment with PTS improved the above histopathological changes 
toward normality. This histological observation showed the protective 
role of PTS in HFD/STZ-induced oxidative stress in insulin resistance mice.
CONCLUSION
From the above observations, we concluded that the oral administration 
of PTS to diabetic mice reversed the changes in glycoprotein 
components in plasma, liver, and kidney. PTS may have a beneficial 
effect by the enhancement of insulin action in diabetic mice as evident 
by the decreased level of serum glucose in PTS-treated diabetic mice. 
Hence, the PTS may be useful in the preparation of drug ingredient for 
the prevention and control of diabetes mellitus.
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Table 3: Changes in the levels of renal glycoproteins in normal and experimental mice
Groups Hexose (mg/g) Hexosamine (mg/g) Fucose (mg/g) Sialic acid (mg/g)
Normal control 27.81±2.11a 14.81±1.12a 11.88±0.90a 7.82±0.59a
Normal+PTS (40 mg/kg b.w) 24.19±1.85a 12.61±0.96a 11.06±0.84a 7.23±0.55a
HFD+STZ 52.30±3.98b 27.08±2.06b 28.60±2.17b 4.78±0.36b
HFD+HFD+PTS (40 mg/kg b.w) 32.65±2.50c 17.13±1.30c 15.82±1.21c 6.12±0.46c
Values are means±SD for six mice. Values not sharing a common superscript (a, b, c) differ significantly at p<0.05 (DMRT). PTS: Pterostilbene, HFD: High-fat diet, 
STZ: Streptozotocin, SD: Standard deviation, DMRT: Duncan’s multiple range test
Fig. 1: Photomicrographs of hematoxylin and eosin stained 
section of mice kidney (100× standard light magnification). 
(a) Normal renal tubular architecture and glomeruli, (b) normal + 
pterostilbene (PTS) showing normal architecture and glomeruli, 
(c) high-fat diet (HFD) +streptozotocin (STZ)-induced kidney 
parenchyma showing significant vacuolar degeneration of renal 
tubular (→) shows severe degeneration along with necrosis of 
tubular vacuolization and dilation of cells, (d) HFD+STZ+ PTS 
showed normal glomeruli maintaining structure similar to 
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